AI Diagnosis to 'Implementation': MOHW and Roche Sign MOU for Kidney Disease Care
AI診斷「落地」!衛福部與羅氏大廠簽MOU 首波瞄準腎臟病推AI臨床決策 - 鉅亨網
Summary
Taiwan's Ministry of Health and Welfare (MOHW) signed an MOU with Roche Diagnostics to launch a pilot program for AI clinical decision support systems focused on chronic kidney disease care. This aims to establish mechanisms for disease risk stratification and early warning of renal function deterioration through a Public-Private Partnership (PPP) model.
Details
The Ministry of Health and Welfare (MOHW) and Roche Diagnostics signed an MOU to launch a pilot program utilizing AI clinical decision support systems. The collaboration, based on a Public-Private Partnership (PPP) model, focuses initially on chronic kidney disease care, aiming to establish mechanisms for disease risk stratification and early warning of renal function deterioration. MOHW stressed that establishing data standardization and governance is crucial for AI to be truly implemented in the medical field. Technically, to overcome past challenges—namely the inconsistency of information systems and data formats across different hospitals—MOHW introduced FHIR (Fast Healthcare Interoperability Resources), an international healthcare data exchange standard. Furthermore, they developed proprietary technology called 'FHIR Box,' which established a common language for cross-hospital electronic medical records without modifying existing Hospital Information Systems (HIS). Currently, this cross-hospital medical record real-time exchange has been completed at three medical centers: Chang Gung, Mackay, and Zhongshan General Hospital. Roche emphasized that AI models require continuous validation using real-world data. They recognized Taiwan's complete data standardization and cross-hospital verification capabilities, noting the availability of a high-quality Real-World Evidence (RWE) environment. The initial focus on chronic kidney disease aims to analyze routine clinical test data via AI, helping medical teams identify high-risk groups early, thereby shifting the care model from 'disease treatment' toward 'precision prevention.'
Original content copyright by respective publishers